Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms (Q46126668)

19 December 2017

title

Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms (English)

1 reference

19 December 2017

0 references

1 reference

11

Ritushree Kukreti

1 reference

19 December 2017

author name string

Meenal Gupta

1

1 reference

19 December 2017

Chitra Chauhan

2

1 reference

19 December 2017

Pallav Bhatnagar

3

1 reference

19 December 2017

Simone Gupta

4

1 reference

19 December 2017

Sandeep Grover

5

1 reference

19 December 2017

Prashant K Singh

6

1 reference

19 December 2017

Meera Purushottam

7

1 reference

19 December 2017

Odity Mukherjee

8

1 reference

19 December 2017

Sanjeev Jain

9

1 reference

19 December 2017

Samir K Brahmachari

10

1 reference

19 December 2017

publication date

1 February 2009

1 reference

19 December 2017

published in

Pharmacogenomics

1 reference

19 December 2017

volume

10

1 reference

19 December 2017

page(s)

277-291

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

Dopamine receptors and the dopamine hypothesis of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Pharmacogenomics: a path to predictive medicine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

DRD2 -141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association of DRD2 gene variant with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

The molecular genetics of schizophrenia: new findings promise new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Genetic abnormalities of chromosome 22 and the development of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A highly significant association between a COMT haplotype and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Impact of complex genetic variation in COMT on human brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

BDNF in schizophrenia, depression and corresponding animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Schizophrenia, III: brain-derived neurotropic factor and genetic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

New strategies for identifying gene-gene interactions in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

A test of translational selection at 'silent' sites in the human genome: base composition comparisons in alternatively spliced genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

COMT: a common susceptibility gene in bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.277

10.2217/14622416.10.2.277

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19207030

1 reference

19 December 2017